
DexCom Revenue Hits $1.19 Billion as Operating Margins Expand by 850 Basis Points
DexCom, Inc.Description
What this story covers
DexCom reported a 15% revenue increase to $1.192 billion in Q1 2026, driven by the G7 rollout and international growth. Significant operational efficiencies led to a near doubling of net income and a robust $2.42 billion cash position.
Story snapshot
CompanyDexCom, Inc.
TickerDXCM
VariantStandard detailed
Duration5:43
Filing type8-K
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001093557-26-000072
Sources1
Full Story Script
Content not available for this story.